Critically, co-inhibition of both RAGE and TLR4 was required to disrupt this autophagic response, effectively sensitizing pancreatic cancer to IRE and underscoring the complexity and therapeutic relevance of extracellular HMGB1 signaling in treatment resistance [99]. The gene discussed is HMGB1; the disease is familial pancreatic carcinoma.